long-acting insulin analogs (Institute of Biotechnology and Antibiotics/IBAkteria)

N/A

Report date: 2025/01/26 18:12:24

Base Information

Drug Namelong-acting insulin analogs (Institute of Biotechnology and Antibiotics/IBAkteria)
Drug Alias Nameinsulin GEKR (Institute of Biotechnology and Antibiotics)insulin GKR (Institute of Biotechnology and Antibiotics)insulin SK3R (IBAkteria)insulin AKR (Institute of Biotechnology and Antibiotics)insulin AKR (IBAkteria) +[7] 
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInsulin ligandInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInstitute Of Biotechnology and Antibiotics
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Biotechnology and AntibioticsIBAkteria Sp z oo
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A